TANOX BIOSYSTEMS, INC. – Trademark Portfolio

Entity Type: 03

TANOX BIOSYSTEMS, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. The owner is based in Houston, TX.

10301 Stella Link

Houston, TX 77025

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DESENSIN
DESENSIN
Abandoned 1997
DESENSIN
DESENSIN
Abandoned 1996
PLATAR
PLATAR
Cancelled 1993
IMSTAT
IMSTAT
Abandoned 1992
MIGIS
MIGIS
Cancelled 1990
IMCHEK
IMCHEK
Abandoned 1990
IMSTAT
IMSTAT
Abandoned 1990
TANOX
TANOX
Cancelled 1990

Trademark Classifications

TANOX BIOSYSTEMS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does TANOX BIOSYSTEMS, INC. have?

TANOX BIOSYSTEMS, INC. has 9 U.S. trademarks filed with the USPTO.

What trademark classes does TANOX BIOSYSTEMS, INC. file in?

TANOX BIOSYSTEMS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is TANOX BIOSYSTEMS, INC.'s trademark registration success rate?

TANOX BIOSYSTEMS, INC. has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.